Unexplored therapeutic opportunities in the human genome

Nature Reviews. Drug Discovery
Tudor I OpreaGergely Zahoránszky-Köhalmi

Abstract

A large proportion of biomedical research and the development of therapeutics is focused on a small fraction of the human genome. In a strategic effort to map the knowledge gaps around proteins encoded by the human genome and to promote the exploration of currently understudied, but potentially druggable, proteins, the US National Institutes of Health launched the Illuminating the Druggable Genome (IDG) initiative in 2014. In this article, we discuss how the systematic collection and processing of a wide array of genomic, proteomic, chemical and disease-related resource data by the IDG Knowledge Management Center have enabled the development of evidence-based criteria for tracking the target development level (TDL) of human proteins, which indicates a substantial knowledge deficit for approximately one out of three proteins in the human proteome. We then present spotlights on the TDL categories as well as key drug target classes, including G protein-coupled receptors, protein kinases and ion channels, which illustrate the nature of the unexplored opportunities for biomedical research and therapeutic development.

References

Apr 30, 1999·Science·S A KliewerT M Willson
Feb 25, 2000·Biological Psychiatry·R M BermanJ H Krystal
Jun 16, 2001·American Journal of Physiology. Gastrointestinal and Liver Physiology·C Sternini
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·K M SakamotoR J Deshaies
Jan 24, 2002·Nature·Howard A RockmanRobert J Lefkowitz
Jan 24, 2002·Nature·Eduardo Marbán
May 23, 2002·Brain : a Journal of Neurology·Dimitri M Kullmann
Aug 9, 2002·Journal of Medicinal Chemistry·Roberto PellicciariTimothy M Willson
Sep 5, 2002·Nature Reviews. Drug Discovery·Andrew L Hopkins, Colin R Groom
Dec 3, 2002·Journal of Negative Results in Biomedicine·Christian Pfeffer, Bjorn R Olsen
Jan 2, 2003·Nature Reviews. Drug Discovery·Jonathan Knowles, Gianni Gromo
May 6, 2003·Nature Genetics·Marianne AbifadelCatherine Boileau
Aug 9, 2003·Nature Reviews. Drug Discovery·Hugo Kubinyi
Apr 3, 2004·Nature Reviews. Drug Discovery·Bryan L RothWesley K Kroeze
Nov 16, 2004·Science·Christopher P AustinFrancis S Collins
Nov 20, 2004·Science·Gwendolyn F ElphickWalter J Atwood
Jun 1, 2005·Drug Discovery Today·Krishan Maggon
Dec 27, 2005·Drug Discovery Today·Philip J HajdukChristin Tse
Nov 11, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Catia Sternini
Jan 5, 2007·The New England Journal of Medicine·Bryan L Roth
Jul 16, 2008·Science·Monica CampillosPeer Bork
Sep 10, 2008·Nature Biotechnology·Jordi MestresRicard V Solé
Oct 10, 2008·Nucleic Acids Research·Joanna AmbergerAda Hamosh
Oct 31, 2009·Nature Reviews. Drug Discovery·Pankaj Agarwal, David B Searls
Nov 3, 2009·Nature·Michael J KeiserBryan L Roth
Nov 27, 2010·The Journal of Physiological Sciences : JPS·Daisuke OkajimaHiroshi Yokota
Feb 11, 2011·Nature·Aled M EdwardsFrank H Yu
Aug 17, 2011·Genome Research·Denis A SmirnovVivian G Cheung
Nov 19, 2011·Nucleic Acids Research·Sarah HunterSiew-Yit Yong
Jan 31, 2012·Chemistry & Biology·Sachin Surade, Tom L Blundell
Feb 9, 2012·Cell and Tissue Research·Kristin DaunerFrank Möhrlen
May 30, 2013·Nature Genetics·UNKNOWN GTEx Consortium
Feb 14, 2014·PloS One·Ashutosh K PandeyRobert W Williams
Apr 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Bruce AlbertsHarold Varmus
May 9, 2014·Nature·Jinseop S KimUNKNOWN EyeWirers

❮ Previous
Next ❯

Citations

Jan 17, 2019·Annals of the New York Academy of Sciences·George R Uhl, Maria J Martinez
Nov 6, 2018·Current Drug Targets·Surovi SaikiaRajeev Sarmah
Apr 26, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Daniel J Cooper, Stephan Schürer
May 23, 2019·Nucleic Acids Research·Alexander LachmannAvi Ma'ayan
Nov 22, 2018·Nucleic Acids Research·Denise Carvalho-SilvaIan Dunham
Oct 30, 2018·Nucleic Acids Research·Oleg UrsuTudor Oprea
Jan 4, 2020·Current Protocols in Bioinformatics·Timothy SheilsTudor I Oprea
Jan 21, 2020·Clinical Pharmacology and Therapeutics·Alex ZhavoronkovTudor I Oprea
May 2, 2020·Chemical Society Reviews·Eugene N MuratovAlexander Tropsha
May 5, 2020·Emerging Topics in Life Sciences·Richard John Wheeler
Dec 12, 2018·PLoS Biology·Tudor I OpreaMichael T McManus
May 29, 2020·SLAS Discovery·Davide RubbiniVincenzo Di Donato
Nov 9, 2019·Nucleic Acids Research·Vasileios StathiasStephan C Schürer
Jul 29, 2020·Nature Metabolism·Zhengdong D ZhangJan Vijg
Aug 25, 2019·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Steve D M Brown, Heena V Lad
Sep 19, 2019·Nature Chemical Biology·Philip P Chamberlain, Lawrence G Hamann
Nov 18, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Evgenia DuevaArtem Cherkasov
Oct 5, 2018·BMC Bioinformatics·Johannes M FreudenbergDeepak K Rajpal
Feb 6, 2020·Nature Reviews. Drug Discovery·Melissa HaendelTudor I Oprea
May 10, 2020·Journal of Molecular Modeling·Clement AgoniMahmoud E Soliman
Sep 22, 2020·Evolutionary Bioinformatics Online·Kabita Baral, Peter Rotwein
Jan 27, 2019·Nature Reviews. Drug Discovery·Joseph H Nadeau, Johan Auwerx
May 12, 2019·Scientific Reports·Maria Ryaboshapkina, Mårten Hammar
Jan 10, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anjali K NathJing-Ruey J Yeh
Mar 22, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Srujan Kumar DondapatiStefan Kubick
Dec 15, 2019·Nature Reviews. Drug Discovery·Erik TambuyzerMarco Prunotto
Jun 30, 2019·SLAS Discovery·Mariafrancesca ScaliseCesare Indiveri
Jan 23, 2020·Scientific Reports·William R ReayMurray J Cairns
Dec 19, 2018·Biochemical Society Transactions·Rosana Reis, Isabel Moraes
Mar 3, 2020·Frontiers in Endocrinology·Robert Brommage, Claes Ohlsson
Sep 3, 2020·Nature Reviews. Drug Discovery·Misty M AttwoodHelgi B Schiöth
Feb 3, 2019·Nature Reviews. Drug Discovery·G Sitta SittampalamChristopher P Austin
Feb 2, 2020·BMC Genomics·Peter Rotwein, Kabita Baral
Sep 27, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Filip Miljković, Jürgen Bajorath
Nov 6, 2020·Nucleic Acids Research·Sorin AvramTudor I Oprea
Nov 16, 2020·European Journal of Medicinal Chemistry·Pedro Martín-Acosta, Xiangshu Xiao
Feb 2, 2021·Journal of Chemical Information and Modeling·Mahendra AwaleChristian Kramer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.